The individuals in the BCR/ABL genetic abnormality cohort exhibited different subtypes, such as BCR/ABL (Ph+, p190 or p210), or Ph-like ALL (Table S4). This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.